The emerging roles of γδ T cells in cancer immunotherapy

Mensurado, S et al. Nature Reviews. Clinical Oncology, 20, 178-191 (2023)

Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer

Foord, E. et al., Science Translational Medicine, Vol 13, Issue 577 (2021)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

de Vries, N.L. et al., Nature 613, 743-750 (2023)

An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer

Wu, Y. et al. Science Translational Medicine, Vol 11, Issue 513 (2019)

The prognostic landscape of genes and infiltrating immune cells across human cancers

Gentles, A. J. et al. Nature Medicine 21, 938-945 (2015)

A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

Wu, Y. et al. Nature Cancer 3, 696-709 (2022)